Cargando…
PRP therapy classification
Autores principales: | Yamato, Masayuki, Watanabe, Natsumi, Yano, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581781/ https://www.ncbi.nlm.nih.gov/pubmed/31245452 http://dx.doi.org/10.1016/j.reth.2015.07.001 |
Ejemplares similares
-
Expedited approval system for regenerative medicine products – Is it unusual?
por: Yano, Kazuo, et al.
Publicado: (2016) -
Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera
por: Watanabe, Natsumi, et al.
Publicado: (2015) -
Bayesian statistics and clinical trial designs for human cells and tissue products for regulatory approval
por: Jokura, Yoji, et al.
Publicado: (2016) -
Non-clinical assessment design of autologous chondrocyte implantation products
por: Ikawa, Taisuke, et al.
Publicado: (2015) -
Compassionate use of drugs and medical devices in the United States, the European Union and Japan
por: Tsuyuki, Kenichiro, et al.
Publicado: (2016)